Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Other Working Capital Changes (2016 - 2025)

Arcadia Biosciences (RKDA) has disclosed Other Working Capital Changes for 12 consecutive years, with -$588000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Working Capital Changes fell 367.27% year-over-year to -$588000.0, compared with a TTM value of -$306000.0 through Sep 2025, down 207.37%, and an annual FY2024 reading of $124000.0, up 41096.01% over the prior year.
  • Other Working Capital Changes was -$588000.0 for Q3 2025 at Arcadia Biosciences, down from -$10000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $572000.0 in Q4 2023 and bottomed at -$588000.0 in Q3 2025.
  • Average Other Working Capital Changes over 5 years is -$29896.9, with a median of -$4895.0 recorded in 2023.
  • Peak annual rise in Other Working Capital Changes hit 104661.9% in 2024, while the deepest fall reached 113433.33% in 2024.
  • Year by year, Other Working Capital Changes stood at -$508000.0 in 2021, then skyrocketed by 82.28% to -$90000.0 in 2022, then soared by 735.56% to $572000.0 in 2023, then fell by 28.15% to $411000.0 in 2024, then plummeted by 243.07% to -$588000.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for RKDA at -$588000.0 in Q3 2025, -$10000.0 in Q2 2025, and -$119000.0 in Q1 2025.